logo

Coverage Reiterated

Share
Updated: Friday, January 19, 2018 11:32:19 AM
Date
Broker
Symbol
Company
Reiterated
Target
1/19/18
Canaccord
Foot Locker Inc.
Buy
$67
1/18/18
Wedbush
PTC Inc.
Outperfom
$78 Up From $69
1/18/18
Wedbush
Fate Therapeutics, Inc
Outperform
$10 Up From $7
1/16/18
Wedbush
Eiger BioPharmaceuticals Inc.
Outperform
$34
1/12/18
Wedbush
New Residential Investment Corp.
Neutral
$20 Up From $16.50
1/12/18
Wedbush
Merus B.V.
Outperform
$32
1/12/18
Wedbush
Taylor Morrison Home Corp.
Neutral
$27
1/12/18
Wedbush
PTC Inc.
Outperform
$69
1/11/18
Wedbush
Progress Software Corp
Neutral
$42 Up From $35
1/10/18
Wedbush
D R Horton Inc.
Neutral
$50
1/10/18
Wedbush
CarMax Inc.
Outperform
$81
1/10/18
Wedbush
Lennar Corp.
Neutral
$62 Up From $60
1/9/18
RBC Capital Markets
Pan American Silver Corp
Outperform
$22
1/9/18
RBC Capital Markets
Pan American Silver Corp
Outperform
$22
1/4/18
Wedbush
Omeros Corp.
Outperform
$47
1/3/18
RBC Capital Markets
The Walt Disney Co
Top Pick
$135 Up From $125
1/3/18
Wedbush
Proofpoint, Inc.
Outperform
$108
1/3/18
Wedbush
Lennar Corp.
Neutral
$60
1/3/18
Wedbush
KB Home
Neutral
$30
12/27/17
Wedbush
United Therapeutics Corp
Outperform
$232 Up From $213
12/22/17
Wedbush
CarMax Inc.
Outperform
$81
12/22/17
Wedbush
Biomarin Pharmaceutical Inc.
Outperform
$110
12/22/17
Wedbush
Kala Pharmaceuticals, Inc.
Outperform
$46
12/20/17
Wedbush
Regulus Therapeutics Inc.
Outperform
$4
12/20/17
Wedbush
Biomarin Pharmaceutical Inc.
Outperform
$110
12/19/17
Wedbush
XOMA LTD
Outperform
$33 Up From $19
12/19/17
Wedbush
Spark Therapeutics
Neutral
$50
12/18/17
Wedbush
Oracle Corp.
Outperform
$55 Down From $58
12/18/17
Wedbush
Fate Therapeutics, Inc
Outperform
$7
12/15/17
RBC Capital Markets
Adobe Systems Inc.
Outperform
$193 Up From $179
12/15/17
Wedbush
Catabasis Pharmaceuticals, Inc.
Outperform
$4
12/15/17
Wedbush
Global Blood Therapeutics
Outperform
$73
12/12/17
RBC Capital Markets
United Natural Foods
Underperform
$34.00
12/11/17
Wedbush
Oracle Corp.
Outperform
$58
12/11/17
Wedbush
Regulus Therapeutics Inc.
Outperform
$4
12/6/17
Wedbush
Clearside Biomedical, Inc.
Outperform
$27
12/6/17
Wedbush
Toll Brothers Inc.
Neutral
$45 Up From $40
12/5/17
Wedbush
Kala Pharmaceuticals, Inc.
Outperform
$46
12/5/17
Wedbush
Proofpoint, Inc.
Outperform
$108 Up From $106
12/4/17
Wedbush
Biomarin Pharmaceutical Inc.
Neutral
$108
1 2 3 4 5